Importantly, analysis using immunohistochemistry and gene amplification by fluorescence in situ hybridization (FISH) showed that progression from benign to atypical or anaplastic MGMs associates with an increase in EGFR protein content, so that EGFR immunostaining directly correlates to tumor grade. The gene discussed is EGFR; the disease is neoplasm.